FIELD: biotechnology.
SUBSTANCE: method for determination of an antigen-binding sites combination is disclosed.
EFFECT: invention allows to obtain bispecific antibodies.
2 cl, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION AND SELECTION OF MOLECULES INCLUDING, AT LEAST TWO DIFFERENT GROUPS, AND APPLICATION THEREOF | 2013 |
|
RU2646159C2 |
HUMANISED HUMAN CD19 ANTIBODIES AND METHODS FOR USE THEREOF | 2016 |
|
RU2731156C1 |
ANTI-TRANSFERRIN RECEPTOR ANTIBODIES WITH INDIVIDUALIZED AFFINITY | 2016 |
|
RU2831724C2 |
ANTIBODIES AGAINST TRANSFERRIN RECEPTOR HAVING INDIVIDUALIZED AFFINITY | 2016 |
|
RU2729416C2 |
METHOD FOR DETECTING ANTIBODIES TO DRUGS WITH RESPECT TO HUMAN OR HUMANISED MEDICINAL ANTIBODIES WITH SUPPRESSED EFFECTOR FUNCTION | 2015 |
|
RU2719642C2 |
COVALENTLY LINKED CONJUGATES CHELICAR-ANTIBODY AGAINST CHELICAR AND USE THEREOF | 2014 |
|
RU2694981C2 |
EMBODIMENTS OF Fc-REGION WITH MODIFIED BINDING PROPERTIES OF FcRn AND PROTEIN A | 2015 |
|
RU2713131C1 |
ANTIBODIES TO BIOTIN AND APPLICATION METHODS | 2013 |
|
RU2630296C2 |
BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | 2014 |
|
RU2693438C2 |
METHOD OF SELECTING ANTIBODIES WITH MODIFIED INTERACTION WITH FcRn | 2015 |
|
RU2714153C2 |
Authors
Dates
2017-12-20—Published
2013-06-25—Filed